These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 7050848

  • 1. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A, Bergogne-Berezin E, Lafaix C.
    Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
    [Abstract] [Full Text] [Related]

  • 2. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J, Coulaud JP, Vivien JM, Berthelot G, Bergogne-Berezin E.
    Nouv Presse Med; 1978 Apr 15; 7(15):1263-7. PubMed ID: 662655
    [Abstract] [Full Text] [Related]

  • 3. [Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
    Albengres E, Houin G, Breau JL, Hirsch A, Saltiel JC, Tillement JP, Chrétien J.
    Nouv Presse Med; 1977 Oct 01; 6(32):2869-71. PubMed ID: 917803
    [Abstract] [Full Text] [Related]

  • 4. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
    Garg SK, Dhand R, Malik SK, Kalra S, Gupta PH, Jha VK, Shukla VK, Lal R.
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug 01; 26(8):417-20. PubMed ID: 3220617
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
    Pilheu JA, Galati MR, Yunis AS, De Salvo MC, Negroni R, García Fernández JC, Mingolla L, Rubio MC, Masana M, Acevedo C.
    Medicina (B Aires); 1989 Aug 01; 49(1):43-7. PubMed ID: 2698437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC, Rathi R, Kishore K, Varshney SC, Varshney DP.
    Indian J Physiol Pharmacol; 1986 Aug 01; 30(1):115-7. PubMed ID: 3818028
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic consequences of measure of inactivation index of isoniazid during antituberculous therapy (author's transl)].
    Houin G, Tillement JP.
    Therapie; 1980 Aug 01; 35(5):597-605. PubMed ID: 7209857
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of ketoconazole with rifampin and isoniazid.
    Engelhard D, Stutman HR, Marks MI.
    N Engl J Med; 1984 Dec 27; 311(26):1681-3. PubMed ID: 6095080
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.
    Probl Tuberk Bolezn Legk; 2004 Dec 27; (3):32-7. PubMed ID: 15338898
    [Abstract] [Full Text] [Related]

  • 14. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E, Ordronneau J, Le Normand Y, Kergueris MF, Larousse C.
    Rev Fr Mal Respir; 1980 Dec 27; 8(3):219-24. PubMed ID: 7187065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S, Singh I, Kaur KJ, Bhade SR, Kaul CL, Panchagnula R.
    Int J Pharm; 2004 May 19; 276(1-2):41-9. PubMed ID: 15113612
    [Abstract] [Full Text] [Related]

  • 17. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R, Arioli V, Furesz S, Bolzoni G.
    Arzneimittelforschung; 1967 May 19; 17(5):529-34. PubMed ID: 5631580
    [No Abstract] [Full Text] [Related]

  • 18. [Changes in the isoniazid inactivation index during antituberculosis treatment in children].
    Bouveret JP, Hanoteau J, Gerbeaux J, Houin G, Tillement JP.
    Arch Fr Pediatr; 1983 Oct 19; 40(8):615-9. PubMed ID: 6606407
    [Abstract] [Full Text] [Related]

  • 19. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT, Vakhmistrova TI, Perova TL.
    Antibiotiki; 1983 Sep 19; 28(9):698-702. PubMed ID: 6638984
    [Abstract] [Full Text] [Related]

  • 20. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V, Ninni A, Natali P.
    Arch Tisiol Mal Appar Respir; 1967 Oct 19; 22(10):859-70. PubMed ID: 4975183
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.